Recombinant factor VIIa for rapid reversal of anticoagulant effect in patients with intracranial hemorrhage: the Israeli experience and review of the literature

Isr Med Assoc J. 2006 Nov;8(11):807-11.
No abstract available

Publication types

  • Review

MeSH terms

  • Adult
  • Aged
  • Anticoagulants* / adverse effects
  • Anticoagulants* / antagonists & inhibitors
  • Anticoagulants* / therapeutic use
  • Factor VII / therapeutic use*
  • Factor VIIa
  • Female
  • Hematoma, Subdural / etiology
  • Humans
  • Intracranial Hemorrhages* / complications
  • Intracranial Hemorrhages* / drug therapy
  • Intracranial Hemorrhages* / physiopathology
  • Israel
  • Male
  • Middle Aged
  • Recombinant Proteins / therapeutic use
  • Stroke / etiology
  • Vitamin K / therapeutic use

Substances

  • Anticoagulants
  • Recombinant Proteins
  • Vitamin K
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa